3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
10
Thoracic
2
Lymphoid
2
Head & Neck
2
Genitourinary
2
Breast
2
Other hematologic neoplasm
1
Gynecologic
1
Dermatologic
1
CNS
1
Conditions
Melanoma
33
Carcinoma, Non-Small-Cell Lung
6
Uveal Melanoma
5
Skin Neoplasms
5
Neoplasms
5
Lymphoma, T-Cell, Cutaneous
4
Kidney Neoplasms
4
Sarcoma
3
Prostatic Neoplasms
3
Mycosis Fungoides
3
Esophageal Neoplasms
3
Colorectal Neoplasms
3
Urinary Bladder Neoplasms
2
Sezary Syndrome
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Lung Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Basal Cell
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urticaria Pigmentosa
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Somatostatinoma
1
Small Cell Lung Carcinoma
1
Pruritus
1
Pancreatic Neoplasms
1
Interventions
pembrolizumab
4
Cyclophosphamide
4
fludarabine
3
Nivolumab
3
Ipilimumab
3
Drug Therapy
3
aldesleukin
2
Biopsy
2
utomilumab
1
trastuzumab deruxtecan
1
sargramostim
1
poly ICLC
1
liposomal doxorubicin
1
fludarabine phosphate
1
erythromycin propionate-N-acetylcysteinate
1
enzalutamide
1
durvalumab
1
brodalumab
1
atezolizumab
1
advexin
1
Sirolimus
1
Radiotherapy, Conformal
1
Quality of Life
1
Psychology, Positive
1
Poly I-C
1
Patient Reported Outcome Measures
1
Observation
1
National Cancer Institute (U.S.)
1
Molecular Diagnostic Techniques
1
Microscopy, Electron
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Blood Specimen Collection
×
Dermatologic
×
Clear all
NCT03787056
2021-07-16
ONCOPRO
Hospices Civils de Lyon
Phase NA
Recruiting
410 enrolled